News releases - Merck.com
WEB6 days ago · August 29, 2024. Merck Provides Update on Phase 3 KEYNOTE-867 and KEYNOTE-630 Trials. August 27, 2024. Merck Announces Phase 3 Trial Initiation for Bomedemstat, an Investigational Candidate for the Treatment of Certain Patients With Essential Thrombocythemia. August 26, 2024.
Merck's Keytruda Obtains its First FDA Approval for Mesothelioma
WEB1 day ago · Merck & Co., Inc. MRK announced that the FDA had approved its blockbuster anti-PD-1 therapy, Keytruda (pembrolizumab), for a new indication. The regulatory body has now approved Keytruda in ...
Merck's Keytruda Secures First FDA-Approval For Rare Form …
WEB2 days ago · Wednesday, the FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with ...
Merck wins first FDA approval for Keytruda as a treatment for ...
WEB3 days ago · Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated ...
What can we help you find? - Merck
WEB23 hours ago · This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject ...
Merck Gets European Panel Backing for Keytruda in Two …
WEB22 hours ago · Sep 20, 2024 5:06am. By Colin Kellaher. Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of ...
Merck: KEYTRUDA Plus Chemotherapy Gets FDA Approval For …
WEB2 days ago · (RTTNews) - Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy KEYTRUDA (pembrolizumab), in combination with ...
FDA approves Merck's drug for rare, deadly lung condition
WEBMar 26, 2024 · The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients...
News & Stories - Merck
WEBSep 12, 2024 · Check out the latest Merck news and stories! Learn more about the leading science and technology company here.
Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives
WEBMar 26, 2024 · Merck MRK -2.06% is making a big bet that its new drug, approved Tuesday in the U.S. for a potentially fatal lung disease, will take the company a long way toward heading off a massive revenue ...